Ghosh S et al. |
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats. |
2008 |
Basic Clin. Pharmacol. Toxicol. |
pmid:18312493
|
Zhang W et al. |
Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia. |
2009 |
J. Cereb. Blood Flow Metab. |
pmid:19471280
|
Shen HC et al. |
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors. |
2009 |
Bioorg. Med. Chem. Lett. |
pmid:19682899
|
Xiao B et al. |
Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide. |
2010 |
J. Pharmacol. Exp. Ther. |
pmid:20501636
|
Zheng C et al. |
Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. |
2010 |
Am. J. Respir. Cell Mol. Biol. |
pmid:20118222
|
Xu X et al. |
Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. |
2010 |
Diabetes |
pmid:20068141
|
Liu JY et al. |
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. |
2010 |
Biochem. Pharmacol. |
pmid:19896470
|
Schebb NH et al. |
Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors. |
2011 |
Anal Bioanal Chem |
pmid:21479549
|
Kopf PG et al. |
Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs. |
2011 |
Hypertension |
pmid:21199991
|
Zhu P et al. |
Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in vivo. |
2011 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:21798825
|
Park SW et al. |
The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells. |
2012 |
Cell Oncol (Dordr) |
pmid:21656078
|
Zhao G et al. |
Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis. |
2012 |
Hum. Gene Ther. |
pmid:22260463
|
Zhao G et al. |
Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury. |
2012 |
J. Lipid Res. |
pmid:22223859
|
Theken KN et al. |
Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. |
2012 |
Atherosclerosis |
pmid:22503544
|
Anwar-Mohamed A et al. |
Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart. |
2012 |
Xenobiotica |
pmid:22680237
|
Nelson JW et al. |
Soluble epoxide hydrolase dimerization is required for hydrolase activity. |
2013 |
J. Biol. Chem. |
pmid:23362272
|
Yang T et al. |
The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins. |
2013 |
Lipids Health Dis |
pmid:24148690
|
Oni-Orisan A et al. |
Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23000418
|
Podolin PL et al. |
In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23434473
|
Chen L et al. |
Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. |
2013 Jul-Aug |
Prostaglandins Other Lipid Mediat. |
pmid:23247129
|